PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 22 filers reported holding PROTEON THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $21,000 | -58.0% | 11,300 | -54.8% | 0.00% | -100.0% |
| Q3 2017 | $50,000 | +31.6% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $38,000 | +11.8% | 25,000 | +28.9% | 0.00% | 0.0% |
| Q1 2017 | $34,000 | +47.8% | 19,400 | +61.7% | 0.00% | – |
| Q4 2016 | $23,000 | -79.5% | 12,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $112,000 | +16.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $96,000 | +3.2% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $93,000 | -50.0% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $186,000 | +11.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $167,000 | -37.7% | 12,000 | -20.0% | 0.00% | -25.0% |
| Q2 2015 | $268,000 | +54.0% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $174,000 | +11.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $156,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $482,000 | 15.66% |
| Pharmstandard International S.A. | 1,165,344 | $1,777,000 | 6.16% |
| Abingworth LLP | 2,017,872 | $3,027,000 | 2.41% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,505,000 | 0.65% |
| RA Capital Management | 1,337,462 | $2,040,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,224,899 | $1,868,000 | 0.10% |
| Perceptive Advisors | 334,116 | $518,000 | 0.03% |
| WEDBUSH SECURITIES INC | 53,439 | $81,000 | 0.01% |
| Baker Brothers Advisors | 298,591 | $455,000 | 0.00% |
| FINANCIAL COUNSELORS INC | 50,000 | $78,000 | 0.00% |